GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Chongqing Taiji Industry (Group) Co Ltd (SHSE:600129) » Definitions » Research & Development

Chongqing Taiji Industry (Group) Co (SHSE:600129) Research & Development : ¥251 Mil (TTM As of Mar. 2024)


View and export this data going back to 1997. Start your Free Trial

What is Chongqing Taiji Industry (Group) Co Research & Development?

Research & Development is the aggregate amount of research and development expenses during the year. Chongqing Taiji Industry (Group) Co's Research & Development for the three months ended in Mar. 2024 was ¥56 Mil. Its Research & Development for the trailing twelve months (TTM) ended in Mar. 2024 was ¥251 Mil.


Chongqing Taiji Industry (Group) Co Research & Development Historical Data

The historical data trend for Chongqing Taiji Industry (Group) Co's Research & Development can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Chongqing Taiji Industry (Group) Co Research & Development Chart

Chongqing Taiji Industry (Group) Co Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Research & Development
Get a 7-Day Free Trial Premium Member Only Premium Member Only 67.18 96.51 102.55 109.42 233.62

Chongqing Taiji Industry (Group) Co Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Research & Development Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 38.03 50.59 60.32 84.69 55.89

Chongqing Taiji Industry (Group) Co Research & Development Calculation

This is the expense the company spent on research and development.

Research & Development for the trailing twelve months (TTM) ended in Mar. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was ¥251 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Chongqing Taiji Industry (Group) Co  (SHSE:600129) Research & Development Explanation

If competitive advantage is created by a patent or tech advantage, at some point it will disappear.

High R&D usually dictates high SG&A which threatens the competitive advantage.


Chongqing Taiji Industry (Group) Co Research & Development Related Terms

Thank you for viewing the detailed overview of Chongqing Taiji Industry (Group) Co's Research & Development provided by GuruFocus.com. Please click on the following links to see related term pages.


Chongqing Taiji Industry (Group) Co (SHSE:600129) Business Description

Traded in Other Exchanges
N/A
Address
No. 1 Taiji Avenue, Fuling District, Chongqing, Chongqing, CHN, 408000
Chongqing Taiji Industry Group is a China-based company engaged in the production and sales of Chinese and Western medicines. It is also engaged in the cultivation of medicinal herbs. Its products mainly include capsules, syrup, oral liquid, lyophilized series, tablets, infusion series, and injections. The company mainly conducts its business in domestic and overseas markets.
Executives
Zhu Ming Xi Director
Xu Wei Guo Supervisors

Chongqing Taiji Industry (Group) Co (SHSE:600129) Headlines

No Headlines